Everyone pls vote for my friend Rachna Kataria, MD (she/her) (link in email from The ISHLT this morning, if you are a member)
Ryan J Tedford MD Indranee Rajapreyar Yevgeniy Brailovsky DO MSc FACC Jeff Teuteberg Vanessa Blumer, MD Silia DeFilippis, MD, FACC Aditi Nayak Mark Belkin Nikhil Narang, MD Jason N. Katz Jennifer Cowger Amit Alam Johanna Contreras, MD, MSc

Happy Diwali! ✨

May we dwell in
Knowledge over ignorance
Compassion over indifference
Health over illness
Love over fear

May our light shine bright 🪔

Racial inequities in access to VAD and transplant persist after consideration for preferences for care: A report from the Registry Evaluation for Vital Information for VADs in Ambulatory Life (REVIVAL) #AHAJournals Tom Cascino, MD U-M IHPI U-M Frankel CVC ahajrnls.org/3s6JYbd

It takes a village to care for transplant patients, meet ours:

“The critical teaching of the Gita is not about anticipating a ‘good’ outcome…

…but about letting go of the attachment to any particular outcome.”

Beautiful perspective my friends.

⁦Anu Lala-Trindade⁩ ⁦Ankur Kalra⁩ academic.oup.com/eurheartj/adva…

Excited to share our comment in JACC Journals on superb work by Veli Topkara Nir Uriel, MD MSc - CAV is a panvascular disease!

So grateful to have learned from Mandeep R. Mehra, MBBS, MSc, FRCP (London) Matthieu P-Galarneau while writing this piece. Brigham and Women's Hospital ICMtl

jacc.org/doi/10.1016/j.…

10/10 recommend applying for this Journal of Cardiac Failure program. Like Robert Mentz, MD said, last year was a HUGE success. Exciting things to come!

Looking for both mentees AND mentors!
Anu Lala-Trindade Andrew J Sauer MD Melvin R. Echols, MD, FACC, FHFSA, FASPC Vanessa Blumer, MD Quentin Youmans, MD, MSc Ashish Correa Jennifer Maning, DO Aditi Nayak

Our center’s experience on the study of CAV post OHT with myocardial flow assessment with cardiac PET now in JACC Journals

Novel insights on long term risk beyond epicardial CAV

Outstanding work led by #KevinClerkin Columbia Cardiovascular Institute

Link: jacc.org/doi/10.1016/j.…

We have had many requests to do another ECG Board review next weekend. Many were unable to attend due to limited capacity on the Zoom this weekend. Will do another one next weekend with unlimited capacity. Will post Zoom link early this week.

🌟New on Journal of Cardiac Failure's YouTube channel!🔥

JCFHightlights 🎥 - short high-impact videos featuring articles from the Journal.

First, Ankeet S. Bhatt, MD, MBA talks with Robert Mentz, MD & Anu Lala-Trindade about digital health application use in the CONNECT-HF trial. Check out the video and article links.

All set 💪🏽, just calculated the HM3RS for a patient I will be presenting at our weekly selection committee meeting tomorrow!

Super easy to use, shout out yet again to the brilliant and creative Subrat Das without whom implementation of this work would have been impossible.

One of the most rewarding experiences of my career thus far!

Would strongly encourage all trainees/EC scientists to submit their best #MCS / #HT work to #ISHLT2023 - if it’s any inspiration, our team is hard at work getting our submissions in on time! 💪🏽

The ISHLT The ISHLTPres

5/ Future directions

👉Will modifying these risk factors impact outcomes?
👉Peri-operative management strategies for high risk patients
👉Validation in a real world cohort
👉Impact on bias in allocation of advanced therapies

4/ How to use this? (Online calc link above)

👉Aid resolution of decisional conflict for patients considering LVAD (Use case attached) by comparing estimated survival without LVAD (SHFM/MAGGIC scores) with HM3RS estimated survival to calculate individualized survival benefit

3/ Why?
👉Facilitate informed and shared decision making
👉Refine ❤ allocation in bridge-to-transplant recipients by discriminating those with ⬆ expected survival (96% at 1 year), from those with ➡ (87%) and ⬇ average expected survival (75%)
👉Enhance LVAD implementation

2/ What?
An intuitive calculator developed and validated in the #MOMENTUM3 cohort including:
👉2 dem variables: Age, prior sternotomy
👉2 🧪: Na, BUN
👉1 echo variable: LVEDD<5.5 cm
👉1 hemodynamic variable: RAP/PCWP>0.6

AUC: 0.76, Pearson r=0.99 for 1-year survival in VC

📢 #eSpaceHF22 by Translational Medicine Academy (TMA): global meeting with FREE reg across 3 time zones/Oct 14-15 chaired by world leaders

Enjoyed discussing #SexDisparities in advanced #HF with Prof. Andrew Coats in the Meet the Experts session

🙏🏽 for the opportunity Javed Butler Shelley Zieroth

Dr.Shelley Zieroth invites you to join her & a diverse faculty at #eSPACEHF22 as they discuss how #HF GLs can be implemented into clinical practice

🗓️ 14-15 Oct.
3⃣ timezones | BKK, PAR, RIO
📍 ONLINE
🔗Free registration | espacehf2022.org

#CardioTwitter #MedEd #CardioEd